Background
The interrelation between sarcopenia and obesity is both reciprocal and pathogenic. Nevertheless, the operational definitions and subsequent findings of sarcopenic obesity (SO) demonstrate variability and inconsistency. This study explored the relationships between sarcopenia and total muscle-to-fat ratio (tMFR), fat mass (FM) ratio, and all-cause mortality.
Methods
This retrospective study recruited inpatients and outpatients aged 18 years and older in a tertiary-hospital-based cohort study from 2018 to 2024. Sarcopenia (SP) was defined by low muscle strength (lowest 20 % of handgrip strength), low physical performance (lowest 20 % of 6-meter walking), and low appendicular skeletal mass index (<7.0 kg/m2 for men; <5.4 kg/m2 for women). Low tMFR or high FM ratio was defined as the lowest and highest quartiles, respectively, for categorizing obesity. The Cox proportional hazard model and Kaplan-Meier curves were used for the primary outcome.
Results
The mean age of the 538 patients was 67.9 ± 14.0 years, and 72.7 % were female. After median (interquartile range) 0.7 (0.2–1.4) years of follow-up, 22 patients had died. Among the 32 patients with sarcopenia and low tMFR, as well as the 31 patients with sarcopenia and high FM ratio, significant characteristics included older age, male predominance, high android-to-gynoid fat ratio, and increased total fat. Older age, sarcopenia, osteoporosis, multimorbidity, serum creatinine, albumin, glycated hemoglobin, and alkaline phosphate were significantly associated with all-cause mortality. After adjusting for age and multimorbidity, SP patients with a low tMFR showed a non-significant trend toward higher all-cause mortality risk (hazard ratio [HR] = 3.26; 95 % confidence interval [CI] = 0.92–11.48), while those with a high FM ratio had a significantly increased risk (HR = 3.83; 95 % CI = 1.10–13.39). Given the limited number of deaths (events), the statistical power of the study may be inadequate, although true associations are likely to exist.
Conclusion
The study underscores the significant associations between low tMFR, high FM ratio, and increased all-cause mortality in patients with sarcopenia. However, considering short follow-up time and limited mortality with a wide hazard ratio in our study, further longer follow up is necessary.
扫码关注我们
求助内容:
应助结果提醒方式:
